Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-247533
Filing Date
2024-10-30
Accepted
2024-10-30 16:01:30
Documents
13
Period of Report
2024-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A d148660d8ka.htm   iXBRL 8-K/A 22712
  Complete submission text file 0001193125-24-247533.txt   148900

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA etnb-20240730.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20240730_lab.xml EX-101.LAB 18702
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20240730_pre.xml EX-101.PRE 11692
15 EXTRACTED XBRL INSTANCE DOCUMENT d148660d8ka_htm.xml XML 4409
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39122 | Film No.: 241410198
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)